TORONTO / Sep 03, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “ Company ” or “ Organigram ”), a leading licensed producer of cannabis, announced today that on August 30, 2024, the Company closed the second of three tranches (the “ Second Tranche ”) of the previously announced C$124,559,674 follow-on strategic equity investment (the “ Investment ”) by BT DE Investments Inc. (the “ Investor... Read More

Net revenue of $41.1 million increased 25% over the prior year period Adjusted EBITDA 1 of $3.5 million versus $(2.9) million over the prior year period Established European foothold with a strategic investment in Sanity Group, a leading German cannabis company Completed landmark clinical study on FAST™ nanoemulsion technology showing faster onset, improved bioavailability of ingestible products Pro-forma cash position of... Read More

FAST™ Nanoemulsion Technology Expected to be a Competitive Advantage for Organigram’s Ingestible Portfolio TORONTO / Aug 07, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), a leading licensed producer of cannabis, is pleased to unveil the preliminary results of its landmark clinical pharmacokinetic (PK) study conducted via the Product Development Collaboration (PDC) on its latest innovation,... Read More

TORONTO / Aug 06, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter fiscal 2024 ended June 30, 2024, on Tuesday, August 13, 2024, prior to market open. The Company will host a conference call to discuss its... Read More

TORONTO / Jul 29, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced the appointment of Craig Harris to the Organigram Board of Directors effective today. Craig brings over 20 years of experience as a commercial lawyer, with a background in private practice and legal and regulatory engagement roles for various... Read More

The partial third tranche investment is expected to enable Organigram to expand its product portfolio, addressing consumer demand for unique and differentiated aromas and flavours. This strategic funding supports the growth and diversification of Organigram’s offerings with a view to enhancing its market position and appeal to consumers. Already a cultivation leader in high THCV cultivars, Organigram will now pilot higher... Read More

Highlights: Concurrent to the investment, Organigram and Sanity Group have entered into a new supply agreement to include significantly higher volumes and the intention to work together on the commercialization of Organigram’s brands and intellectual property (IP) in Germany. Investment in the form of an unsecured convertible note combined with a minority equity stake in Sanity Group. Organigram entitled to appoint a... Read More

Over a three-year period, Organigram expects to supply 1,700 kilograms of high-quality medical cannabis flower to Avida Medical, with 500 kilograms expected to be delivered in the first year of the agreement. Avida Medical to become Organigram’s second international medical cannabis customer in the UK. Organigram to grant... Read More

21% growth in recreational net revenue year-over-year First Jupiter private placement tranche closed adding $41.5 million of cash bringing Organigram's closing cash balance at quarter-end to $83.6 million Subsequent to quarter end, closed $28.8 million oversubscribed marketed offering, which when combined with the remaining two anticipated Jupiter tranches will increase cash position by additional $110 million Company's... Read More

TORONTO / May 08, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2024 ended March 31, 2024, on Tuesday, May 14, 2024, prior to market open. The Company will host a conference call to discuss its... Read More

The fifth annual Report on Business editorial benchmark identifies top-level Canadian businesses with the highest executive gender diversity. TORONTO / Apr 08, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce it has been recognized on the 2024 Report on Business ‘Women Lead Here’ list for gender... Read More

Success of the brand owed to ongoing pipeline of innovative products designed to delight consumers. TORONTO / Apr 03, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, celebrates a monumental achievement as its SHRED brand surpasses the $200 million mark in yearly retail sales. 1 SHRED revolutionized the cannabis industry in... Read More

Including over-allotment Company raises C$28.8 million in gross proceeds improving already strong balance sheet TORONTO / Apr 02, 2024 / Business Wire / Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI; NASDAQ: OGI) announces today the closing of its previously announced underwritten public offering of units of the Company (the “ Units ”) for total gross proceeds of C$28,750,230 (the “ Offering ”). The... Read More

TORONTO / Mar 27, 2024 / Business Wire / Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today that, in connection with its previously announced overnight marketed public offering of units of the Company (the “Units”), it has entered into an underwriting agreement with ATB Securities Inc., as lead underwriter, on behalf of itself and a syndicate of underwriters to sell 7,740,000... Read More

TORONTO / Mar 26, 2024 / Business Wire / Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announces today an overnight marketed public offering of units of the Company (the “Units”) for total gross proceeds of approximately C$25 million (the “Offering”). The Offering is expected to be completed pursuant to an underwriting agreement to be entered into between the Company and ATB Securities... Read More

North Carolina-based Open Book Extracts is a leading ingredient provider, product formulator and manufacturer of hemp-derived extracts and products. TORONTO / Mar 26, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) is pleased to announce a US $2 million minority... Read More

TORONTO / Mar 22, 2024 / Business Wire / Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced today that, despite strong evidence supporting its classification as an ingestible extract, it has received a final redetermination from Health Canada that its patented Edison Jolts lozenge products (the “Products”) are to be classified as edible cannabis. The final redetermination follows the... Read More

Revised Excise Framework Remains One of the Most Critical Reforms Required to Ensure the Long-Term Viability of the Cannabis Industry TORONTO / Feb 28, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”) enthusiastically supports the Standing Committee on Finance’s recent recommendation on the Excise Duty framework. In a recently released report, titled ‘Shaping our... Read More

HIGHLIGHTS $124.6 million strategic investment from BAT announced in November 2023 approved by shareholders, with first of three tranches now funded at $3.22 per share for proceeds of $41.5 million Achieved positive Adjusted EBITDA 1 and positive cash flow from operations of $7.7 million Improved sequential... Read More

TORONTO / Feb 07, 2024 / Business Wire / Organigram Holdings Inc . (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2024 ended December 31, 2023, on Tuesday, February 13, 2024, prior to market open. The Company will host a conference call to discuss... Read More

TORONTO / Jan 31, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis today announced that it has sent its first shipment of bulk dried flower to the medical division of German cannabis company, Sanity Group, a health and sciences organization dedicated to the medical applications of cannabinoids. Organigram is pleased to complete... Read More

TORONTO / Jan 24, 2024 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “ Company ” or “ Organigram ”), a leading licensed producer of cannabis, announced today that it has closed the first of three tranches of the previously announced C$124,559,674 follow-on strategic equity investment (the “ Investment ”) by BT DE Investments Inc. (the “ Investor ”), a wholly owned subsidiary of British American... Read More

TORONTO / Jan 19, 2024 / Business Wire / Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), announced the appointment of Karina Gehring to the Organigram Board of Directors at the Company’s annual general and special meeting held on January 18, 2024. “We are thrilled to welcome Karina to our Board of Directors. Her extensive expertise in marketing and brand management combined with her ongoing... Read More

TORONTO / Jan 18, 2024 / Business Wire / Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders (the “ Shareholders ”) held virtually on January 18, 2024 (the “ Meeting ”). Election of Directors Each of the nine nominees listed in the Company’s management information circular dated December 20, 2023... Read More

Special Meeting to Approve $124.6 Million Investment from BAT at $3.2203/share and Creation of “Jupiter” Strategic Investment Pool TORONTO / Dec 29, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “ Company ” or “ Organigram ”), a leading licensed producer of cannabis, announced today that it has mailed and filed a management information circular (the “ Circular ”) and related materials (the “... Read More

Domestic share growth in several key categories continues to be driven by innovation excellence and industry-leading R&D. Organigram continues to take a leadership position in industry fighting THC mislabelling (inflation). Company fortifying itself with recently announced BAT-Jupiter $124.6 million private placement... Read More

TORONTO / Dec 18, 2023 / Business Wire / Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI) is pleased to announce that Greg Guyatt CPA, CA, formerly of Phoena Holdings Inc. (“Phoena”), has been appointed to the role of Chief Financial Officer effective January 8, 2024. Mr. Guyatt will lead Organigram’s Finance and IT divisions and will report directly to Beena Goldenberg, Organigram’s Chief... Read More

TORONTO / Dec 14, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and fiscal 2023 ended September 30, 2023, on Tuesday, December 19, 2023, before market open. The Company will host a conference call to discuss... Read More

Organigram wins “Innovation of the Year” two years in a row cementing its reputation as a disruptive leader in the cannabis sector TORONTO / Dec 13, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or “Organigram”), is... Read More

Organigram to advance the conversion of its grow rooms with custom designed, F1 Hybrid seeds Organigram expects to soon be able to begin low-cost production of high-potency, terpene-rich cultivars destined for various products and blends across its brand portfolio. Organigram is on track to convert more than 30% of its cultivation space in the Moncton facility to F1 Hybrid seed grow by end of FY24. The high-potency,... Read More

TORONTO / Nov 10, 2023 / Business Wire / The Board of Directors (the “Board”) of Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI) today announced that Derrick West has informed Organigram that he will transition away from his role as Chief Financial Officer (“ CFO ”) in order to take time to focus on his health and recovery following surgery later this month. Paolo De Luca, current Chief... Read More

Organigram and BAT deepen partnership through C$124.6 million investment with 38.7 million shares to be issued over three tranches Organigram to use C$83.1 million of the investment to create “Jupiter,” a strategic investment pool designed to expand Organigram’s geographic footprint and capitalize on emerging growth opportunities C$41.5 million of the investment will be used for general corporate purposes Investment enhances... Read More

Achieves #2 Market Share Over the Last Two Months TORONTO / Oct 18, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to provide a corporate update. Market Share Momentum Market share continues to be an important... Read More

TORONTO / Oct 11, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “ Company ” or “ Organigram ”), a leading licenced producer of cannabis, announced today that it has obtained a receipt for a final short form base shelf prospectus (the “ Base Shelf Prospectus ”) filed with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement... Read More

TORONTO / Sep 25, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “ Company ” or “ Organigram ”), a leading licenced producer of cannabis, announced today that it has filed a preliminary short form base shelf prospectus (the “ Base Shelf Prospectus ”) with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10... Read More

TORONTO / Sep 01, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announces today that Ms. Caroline Ferland has resigned from the Board of Directors (“the Board”) effective immediately. Ms. Ferland was a board member nominee appointed by BAT. “In her short time on the Board, Ms. Ferland made considerable contributions to... Read More

First lineup of THCV products enabled by Organigram’s strategic investment in Phylos Bioscience TORONTO / Aug 28, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to launch its first range of whole-flower derived THCV products through the Company’s popular SHRED and newly re-launched Trailblazer brands. Reaffirming... Read More

Trailblazer returns to the Canadian marketplace with a new range of products TORONTO / Aug 21, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the relaunch of one of Canada’s best known cannabis brands,... Read More

Organigram to supply 4C LABS with high-quality Medical Cannabis for distribution to UK Medical Cannabis patients Organigram chosen by 4C LABS to be the preferred supplier of Medical Cannabis flower to deliver innovative new products to the UK market First year of the agreement expected to reach approximately 600 kilograms of high margin Medical Cannabis flower, with increasing targets in the following 2 years Organigram to... Read More

TORONTO / Aug 10, 2023 / Business Wire / Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced today that the Federal Court of Canada (the “Court”) has granted Organigram’s application for judicial review of a decision of Health Canada determining that the Edison Jolts lozenges (the “Products”) are to be classified as edible cannabis. The Court found there was a breach of procedural... Read More

Both SHRED Dartz and Holy Smokes come in 10x0.4g packs and are rolled with 100% organic hemp paper providing a more natural and elevated cannabis experience TORONTO / Aug 02, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is... Read More

TORONTO / Jul 07, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter fiscal 2023 ended May 31, 2023, on Thursday, July 13, 2023, after market close. The Company will host a conference call to discuss its results... Read More

TORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI) announced today that, further to its earlier press releases, it has completed the proposed consolidation of the Company’s issued and outstanding common shares at a consolidation ratio of four (4) pre-consolidation common shares for every one (1) post-consolidation common share (the “ Share Consolidation... Read More

SHRED X Heavies is one of the only infused pre-roll offerings to combine diamonds, distillate, and botanical terpenes, providing an unparalleled experience in a convenient 0.5g pre-roll. TORONTO / Jun 21, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading... Read More

TORONTO / Jun 19, 2023 / Business Wire / Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI) announced today that its Board has approved the consolidation of the Company’s issued and outstanding common shares at a consolidation ratio of four (4) pre-consolidation common shares for every post-consolidation common share (the “ Share Consolidation ”). The Share Consolidation is being implemented to... Read More

Phylos is a recognized leader in seed genetics with a growing IP portfolio including the highest potency THCV cultivars available Organigram will launch new products in Canada containing THCV, a novel and rare cannabinoid referred to by consumers as “Diet Weed”, and that is gaining popularity for its reported effects of... Read More

Organigram to supply the medical division of German cannabis company Sanity Group with high-quality medical flower for distribution in Germany. Germany is expected to legalize recreational cannabis and remains the largest addressable cannabis market in Europe as a result. Both Organigram and Sanity Group have received strategic investments from BAT TORONTO / May 23, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ:... Read More

TORONTO / May 19, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company" or "Organigram"), a leading licensed producer of cannabis, announced today that its wholly-owned subsidiary, The Edibles and Infusions Corporation (“EIC”) has met certain of the remaining earnout milestones that formed part of the terms of its acquisition in April, 2021. Organigram acquired EIC in April 2021 for... Read More

Continues trend of improving Adjusted Gross Margin and fifth consecutive quarter of positive Adjusted EBITDA FINANCIAL HIGHLIGHTS Net revenue of $39.5 million, up 24% from $31.8 million in the same prior-year period. Adjusted Gross Margin 1 of $13.4 million or 34%, compared to $8.3 million or 26% in the same prior year period, reflecting improvements from increased efficiencies, higher sales volume and increased... Read More

TORONTO / Apr 04, 2023 / Business Wire / Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter fiscal 2023 ended February 28, 2023, on Tuesday, April 11, 2023, after market close. The Company will host a conference call to discuss its... Read More

Organigram’s deal with Greentank which brings new heating technology is anticipated to grow Organigram’s vape market position with plans to launch prior to the end of its current fiscal year Investment includes 18-month exclusivity right in Canada for the new technology incorporated into 510 vape cartridges $4 million USD... Read More

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced that BAT has designated Ms. Caroline Ferland as a nominee to Organigram’s board of directors (the “Board”). Caroline Ferland is a lawyer with extensive international experience assisting multinational companies to operate with confidence and integrity in highly regulated and high-risk environments. As the first Group Head of Business... Read More

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), announced that it has received notification from Health Canada that Health Canada has determined that certain Jolts lozenge products in their 100 mg THC per package format (the “Products”) have been improperly classified as an “extract” rather than an “edible” under the Cannabis Regulations. The Company launched the Products in August 2021... Read More

Organigram Holdings Inc. (“ Organigram ” or the “ Corporation ”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual general and special meeting of shareholders held on February 28, 2023 (the “ Meeting ”). Each of the nine nominees listed in the Corporation’s management information circular dated January 16, 2023 (the “ Circular ”) provided in connection with the Meeting was elected as a director of... Read More

SHRED aims to introduce hash to a new generation of consumers with 10 pre-cut, botanical terpene-infused hash Rip Strips Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of SHRED X Rip-Strip Hash, a first-of-its-kind innovation in the Canadian cannabis industry. This botanical terpene-infused hash is unlike any other... Read More

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI; NASDAQ: OGI), today announced that it received notification (the “Notification”) from The Nasdaq Stock Market LLC (“NASDAQ”) that it is not in compliance with the minimum bid price requirement in NASDAQ Listing Rule 5450(a)(1) for continued listing on the NASDAQ Global Select Market, since the closing bid price for the Company’s common shares listed on... Read More

Achieves record Adjusted Gross Margin and fourth consecutive quarter of positive Adjusted EBITDA FINANCIAL HIGHLIGHTS Net revenue of $43.3 million, up 43% from $30.4 million in the same prior-year period. Adjusted EBITDA 1 of $5.6 million, the fourth consecutive quarter of positive Adjusted EBITDA, compared to negative Adjusted EBITDA of $1.9 million in the same prior year period. Adjusted Gross Margin 1 of $12.8 million or... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2023 ended November 30, 2022, on Thursday, January 12, 2023, before market open. The Company will host a conference call to discuss its results with details as follows: Date:... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of a leading licensed producer of cannabis (the “Company” or “Organigram”), is pleased to announce it has won KIND Magazine’s (“KIND”) Cannabis Company of the Year award. Considered KIND’s marquee award , Cannabis Company of the Year is presented to the licensed producer that the KIND editorial team believes demonstrates the best combination of people,... Read More

Continues trend of record quarterly net revenue and positive Adjusted EBITDA while growing share of adult recreational market Q4 FISCAL 2022 FINANCIAL HIGHLIGHTS Continued record growth in net revenue, reaching $45.5 million, the highest in the history of the Company, up 83% from $24.9 million in the same prior-year period and 19% from $38.1 million in Q3 Fiscal 2022. Adjusted EBITDA 1 of $3.2 million, the third consecutive... Read More

HOLY MOUNTAIN product portfolio will primarily focus on value whole flower and concentrates Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of HOLY MOUNTAIN, the Company’s newest value brand featuring an initial... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its annual and fourth quarter fiscal 2022 ended August 31, 2022 on Monday, November 28, 2022, after market close. The Company will host a conference call to discuss its results with details as follows:... Read More

Organigram to supply Israeli pharmaceutical grade cannabis leader InterCure with up to 20,000 kg of dried flower over multiple years Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”) a leading Canadian licensed producer of cannabis and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) Israel’s largest and most established pharmaceutical cannabis... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the third quarter ended May 31, 2022 (“Q3 Fiscal 2022”). “We are pleased to see continued strength in our recreational business with our increasing market share. We achieved record net revenue results which we expect to surpass again in Q4 on the strength of new product... Read More

Organigram Holdings Inc . (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter 2022 ended May 31, 2022 on Thursday, July 14, 2022 before market open. The Company will host a conference call to discuss its results with details as follows: Date: July 14, 2022 Time:... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), and its subsidiary Organigram Inc. (together, the "Company" or "Organigram"), a leading licensed producer of cannabis in Canada, has reached a proposed settlement (“Settlement”) in a previously disclosed class action related to medical cannabis that was voluntarily recalled in December 2016 and January 2017 (“Class Action”). The Supreme Court of Nova Scotia (the “Court”)... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2022 (“Q2 Fiscal 2022”). “The culture of innovation and consumer focus we are building at Organigram has enabled us to not only create brands that are embraced by consumers, but continually... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter 2022 ended February 28, 2022 on Tuesday, April 12, 2022 before market open. The Company will host a conference call to discuss its results with details as follows: Date: April 12, 2022... Read More

Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively “Organigram” or the “Company”), a leading licensed producer of cannabis, provided a corporate update today. Continued Market Share Momentum Organigram continues its strong market share growth trajectory in Canada, securing the #3 market share position 1 among Canadian licensed producers for the second month in a row.... Read More

Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively “Organigram” or the “Company”), a leading licensed producer of cannabis, is pleased to announce the launch of its social impact strategy ‘Organigram Operating for Good’ with the purpose of ‘Building healthy communities where we live and work.’ As part of this strategy the Company has committed to giving back by joining... Read More

Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively “Organigram” or the “Company”), a leading licensed producer of cannabis, is pleased to announce that BAT has invested an additional C$6.3 million into Organigram to enhance its equity ownership position in Organigram from 18.8% to 19.5% as of December 31, 2021 by exercising its rights pursuant to an investor rights... Read More

Organigram Holdings Inc. (“ Organigram ” or the “ Corporation ”) (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual meeting of shareholders held on February 23, 2022 (the “ Meeting ”). Each of the eight nominees listed in the Corporation’s management information circular dated January 18, 2022 (the “ Circular ”) provided in connection with the Meeting was elected as a director of Organigram at the... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the first quarter ended November 30, 2021 (“Q1 Fiscal 2022”). “Our record-breaking results in the first quarter of Fiscal 2022 are a testament to our successful strategy to create innovative, high-quality products that align with... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its first quarter fiscal 2022 ended November 30, 2021 on Tuesday, January 11, 2022 before market open. The Company will host a conference call to discuss its results with details as follows: Date:... Read More

As an early investor in biosynthesis, Organigram Holdings Inc. (NASDAQ: OGI), (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, and Hyasynth Biologicals Inc. (“Hyasynth”) a private biotechnology company and pioneer in the field of cannabinoid science and biosynthesis are pleased to announce that Organigram has acquired an additional $2.5 million of... Read More

Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (collectively “Organigram” or the “Company”), a leading licensed producer of cannabis, is pleased to announce it has acquired all of the issued and outstanding shares of Laurentian Organic Inc. (“Laurentian”), in a cash and share transaction for aggregate consideration of $36 million, plus earnout consideration (the “Earnout... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the fourth quarter ended August 31, 2021 (“Q4 Fiscal 2021”). “The results in Q4 Fiscal 2021 demonstrate the momentum we have achieved from our efforts to lead innovation and increase efficiencies. In the quarter, we introduced... Read More

Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of Monjour, the Company’s new wellness brand, offering high-quality, CBD-forward products for consumers seeking easy and... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its fourth quarter and full year fiscal 2021 ended August 31, 2021 on Tuesday, November 23, 2021 before market open. The Company will host a conference call to discuss its results with details as... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) (the “Company” or “Organigram”), the parent company of Organigram Inc., a leading licensed producer of cannabis, provided a corporate update today. Market Share Momentum Organigram believes that market share continues to be an important indication of success for a licensed producer (“LP”) as sell through to end consumers is a strong predictor of long-term sustainable revenue.... Read More

Organigram Holdings Inc. (“ Organigram ” or the “ Corporation ”) (TSX: OGI) (NASDAQ: OGI) announced today that it has obtained a receipt for a final short form base shelf prospectus (the “ Base Shelf Prospectus ”) filed with the securities commissions in each of the provinces and territories of Canada. A corresponding shelf registration statement on Form F-10 (the “ Registration Statement ”) has been filed with the United... Read More

Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce the launch of Edison Cannabis Co. (“Edison”) JOLTS, Canada’s first flavoured high potency THC lozenge. Edison JOLTS are available in a package of 10 mint flavoured lozenges with 10 mg of THC per lozenge for a total of 100mg per pack. This... Read More

Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading Canadian producer of cannabis, is pleased to announce Beena Goldenberg, formerly Chief Executive Officer of The Supreme Cannabis Company Inc. and previously Chief Executive Officer at Hain-Celestial Canada, ULC, has been appointed the Company’s new Chief Executive Officer (CEO). Ms.... Read More

Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of the Cannabis Innovators Panel, a cannabis consumer panel offering real-time insights into consumer preferences, usage occasions, and future development opportunities. This online panel will engage with 2,500 participants across... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the third quarter ended May 31, 2021 (“Q3 2021”). “We are pleased with the growth in revenue in Q3 as we were better staffed to fulfill the demand for our revitalized product portfolio, which continues to resonate well with... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its third quarter Fiscal 2021 ended May 31, 2021 on Tuesday July 13, 2021 before market open. The Company will host a conference call to discuss the results: Date: July 13, 2021 Time: 8:00 am Eastern Time To... Read More

Organigram Holdings Inc. (" Organigram " or the " Corporation ") (TSX: OGI) (NASDAQ: OGI) announced today that it has a filed a preliminary short form base shelf prospectus (the " Base Shelf Prospectus ") with the securities commissions in each of the provinces and territories of Canada . A corresponding shelf registration statement on Form F-10 (the " Registration Statement ") has been filed with the United States... Read More

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce that it is currently recruiting for as many as 75 positions, across most functional areas of the Company. Positions include those in Operations, Production, Sanitation, Cultivation, Sales, Marketing, Research, and Quality Assurance. The Company is... Read More

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the appointment of Megan McCrae as the Company’s Senior Vice President of Marketing and Communications. Ms. McCrae will assume her new role effective today. A seasoned marketing expert, Ms. McCrae has 17 years experience in consumer packaged goods... Read More

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, is pleased to announce the launch of Big Bag o’ Buds, a lineup of dried flower products featuring a roster of well-known genetics and an exciting rotation of one-time offerings (OTO) in a 28g format. “Customers across the country continue to express the importance... Read More

Organigram Holdings Inc. (“Organigram” or the “Company”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the appointment of Borna Zlamalik as the Company’s Vice President of Innovation. Mr. Zlamalik will assume his new role effective today. In his new role, Mr. Zlamalik will draw upon his international expertise in cannabis and cannabinoid-based product... Read More

The Board of Directors (the “Board”) of Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI) has confirmed that Greg Engel is stepping away from his role as CEO effective today, however he will continue to act as a special advisor to the Board through a transition period. The Board is grateful for the contributions Greg has made since joining the Company in 2017. Peter Amirault, current Board... Read More

As part of the continued expansion of its Edison Cannabis Co. (“Edison”) line of products, Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of two new Edison dried flower strains including the potent GMO Cookies and legendary citrus diesel MAC-1. Both strains feature a distinct... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (together, the “Company” or “Organigram”), a leading licensed producer of cannabis, announced its results for the second quarter ended February 28, 2021 (“Q2 2021”). “Although Q2 2021 results were challenged by industry dynamics, COVID-19 and staffing limitations at our facility, we believe there are excellent prospects ahead for the... Read More

Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI), the parent company of Organigram Inc. (together with OGI, “Organigram” or the “Company”), a leading producer of cannabis, is pleased to announce it has acquired all of the issued and outstanding shares of The Edibles & Infusions Corporation (“EIC”) (the “EIC Acquisition”) for consideration of $22.0 million, plus up to an additional $13.0 million in shares (the... Read More

AgraFlora Organics International Inc. (“ AgraFlora ” or the “ Company ”) (CSE: AGRA ) (Frankfurt: PU31 ) (OTCPK: AGFAF ) is pleased to announce that it and its fellow shareholders have entered into an agreement to sell The Edibles & Infusions Corporation (“EIC”), an entity of which AgraFlora owns 43%, to Organigram Holdings Inc. (TSX: OGI and NASDAQ: OGI) (“OGI”), for consideration of $22 million in shares of OGI (the “EIC... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today it will report earnings results for its second quarter Fiscal 2021 ended February 28, 2021 on Tuesday April 13, 2021 before market open. The Company will host a conference call to discuss the results: Date: April 13, 2021 Time: 8:00 am Eastern Time... Read More

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (collectively, the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce that the Company has repaid all outstanding balances (approximately $58.5 million) (the “Repayment”) under the facilities provided under its credit agreement (the “Credit Agreement”) dated November 27, 2020, with Bank of... Read More

Building on the Company’s ongoing genetic exploration and product development program, Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of two new recreational product offerings: Indi,... Read More

Organigram Holdings Inc. (“OGI”, TSX: OGI and NASDAQ: OGI) is pleased to announce a C$221 million strategic investment from a wholly-owned subsidiary of BAT (LSE:BATS and NYSE:BTI). The BAT subsidiary has subscribed for approximately 58.3 million common shares of OGI, which represents a 19.9% equity interest 1 on a post-transaction basis for total proceeds of approximately C$221 million (“Investment Proceeds”) at a price per... Read More

As part of its consumer-first product innovation strategy, Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading producer of cannabis, is pleased to announce the launch of two new additions to the Company’s recreational cannabis product portfolio: SHRED Tropic Thunder Jar of Joints and Trailblazer SNAX Milk Chocolate Bars. “At Organigram,... Read More

Organigram Holdings Inc. (or the " Corporation ") (TSX: OGI) (NASDAQ: OGI) announced today the results of voting at its annual meeting of shareholders held on February 23, 2021 (the " Meeting "). Each of the eight nominees listed in the Corporation's management information circular dated January 18, 2021 (the " Circular ") provided in connection with the Meeting was elected as a director of Organigram at the Meeting.... Read More

Organigram Holdings Inc. (“ Organigram ” or the “ Company ”) (TSX: OGI) (NASDAQ: OGI) announces Matt Rogers, Senior Vice President, Operations, will be leaving Organigram at the end of May 2021 to pursue other interests. Organigram would like to thank Matt for his efforts helping Organigram grow from a licensed producer of medical cannabis to one of the country’s leading producers of both medical and adult use recreational... Read More